Environmental Controls & Personal Protection to Reduce the Risk of Infection In addition to administrative controls, environment controls and personal protection [32] are also essential in reducing ...

Breast tuberculosis, a rare form of extrapulmonary tuberculosis, represents a diagnostic challenge due to its nonspecific clinical and imaging features that can mimic both benign and malignant breast ...

KARACHI, March 21: Healthcare providers need to be urgently educated about proper tuberculosis management particularly regarding mild to severe side effects of anti-TB drugs. This was discussed in a ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. In 2023, an estimated 10.8 million people contracted TB, with 1.25 million deaths, according to the World Health ...

The American Thoracic Society (ATS), the U.S. Centers for Disease Control and Prevention (CDC), and the Infectious Diseases Society of American (IDSA) announce the release of the first completely ...

Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples // Panel significantly accelerates TB outbreak tracking and ...

In a recent study published in the journal Clinical Infectious Diseases, researchers reported on the treatment of rifampin-resistant tuberculosis in the United States (U.S.) using the Food and Drug ...

Tuberculosis (TB) is caused by Mycobacterium tuberculosis. For decades, it has been among the top 10 reasons of death globally, and the number one infectious killer. Furthermore, it is still ...

A TB patient receiving counseling and treatment at Kerugoya Hospital TB Management Center. [Jane Mugambi, Standard] African countries should increase their investment in Tuberculosis and especially in ...

A significant proportion of people in the community with pulmonary tuberculosis (TB) have subclinical disease, according to a meta-analysis involving survey studies across Africa and Asia. In adjusted ...

Extensive drug resistance in TB is not a new phenomenon. It is created when patients with multidrug-resistant TB (MDR-TB) are treated with second-line anti-TB drugs but fail to be cured. The first ...